Reconciliations of Equity (Tables)

3 Months Ended

Mar. 31, 2021

Equity [Abstract]

Reconciliations of Total Equity

Below are reconciliations of total equity, Company equity and equity attributable to noncontrolling interests for the three months ended March 31, 2021 and 2020:

(In thousands, except share and per share amounts)	Total			Common Stock		Additional Paid-in Capital		Common Treasury Stock			Accumulated Other Comprehensive Income (Loss)			Retained Earnings			Noncontrolling Interest (1)
Balance, December 31, 2020	$	988,365		$	26,658	$	206,716	$	(133,629	)	$	(136,881	)	$	1,023,829		$	1,672
Issuance of 5,786 shares of common stock under stock option plan		381			6		375		—			—			—			—
Purchase of 8,300 shares of common stock		(989	)		—		—		(989	)		—			—			—
Stock-based and deferred compensation		8			62		2,380		(2,434	)		—			—			—
							—
Net income		40,611			—		—		—			—			40,611			—
Other comprehensive income (loss)		(17,569	)		—		—		—			(17,561	)		—			(8	)
Cash dividends paid:
Common stock ($0.305 per share)		(6,861	)		—		—		—			—			(6,861	)		—
Balance, March 31, 2021	$	1,003,946		$	26,726	$	209,471	$	(137,052	)	$	(154,442	)	$	1,057,579		$	1,664

(In thousands, except share and per share amounts)	Total			Common Stock		Additional Paid-in Capital		Common Treasury Stock			Accumulated Other Comprehensive Income (Loss)			Retained Earnings			Noncontrolling Interest (1)
Balance, December 31, 2019	$	892,496		$	26,493	$	193,135	$	(114,139	)	$	(136,170	)	$	922,464		$	713
Issuance of 2,747 shares of common stock under stock option plan		155			3		152		—			—			—			—
Purchase of 89,225 shares of common stock		(7,243	)		—		—		(7,243	)		—			—			—
Stock-based and deferred compensation		1,116			45		2,374		(1,303	)		—			—			—
Net income		27,539			—		—		—			—			27,545			(6	)
Other comprehensive income (loss)		(40,389	)		—		—		—			(40,376	)		—			(13	)
Cash dividends paid:
Common stock ($0.275 per share)		(6,202	)		—		—		—			—			(6,202	)		—
Balance, March 31, 2020	$	867,472		$	26,541	$	195,661	$	(122,685	)	$	(176,546	)	$	943,807		$	694

(1) Reflects the noncontrolling interest in the Company’s China joint venture.